📰 Breaking News: Lessons Learnt & Insights from DSTBTD Restructuring Plan

Notices to creditors (MVL)

H2 Pharma Consulting Limited

active Company no. 06206575 Published 21 August 2026

In short: H2 Pharma Consulting Limited (company no. 06206575) entered members' voluntary liquidation, a solvent and planned closure, according to a Notices to creditors (MVL) notice published in The London Gazette on 21 August 2026. The office holders are Mark Holborow (IP No. 22834) of Crowe UK LLP, 2nd Floor, Medway Bridge House, 1-8 Fairmeadow, Maidstone, Kent, ME14 1JP; Steven Edwards (IP No. 26090) of Crowe , appointed 17 August 2026. The company's business: other business support service activities not elsewhere classified, trading from The Carriage House, Mill Street, Maidstone, Kent, ME15 6YE.

The joint liquidators of H2 PHARMA CONSULTING LIMITED announce final creditor distributions in a members’ voluntary liquidation and state that any remaining funds will be paid to shareholders.

Notice details

Company
H2 PHARMA CONSULTING LIMITED
Company number
06206575
Nature of business
Other business support service activities not elsewhere classified
Type of liquidation
Members’ voluntary liquidation
Registered office
The Carriage House, Mill Street, Maidstone, Kent, ME15 6YE
Principal trading address
The Carriage House, Mill Street, Maidstone, Kent, ME15 6YE
Date of appointment
17 August 2026
Liquidator(s)
Mark Holborow (IP No. 22834) of Crowe UK LLP, 2nd Floor, Medway Bridge House, 1-8 Fairmeadow, Maidstone, Kent, ME14 1JP; Steven Edwards (IP No. 26090) of Crowe UK LLP, 2nd Floor, Medway Bridge House, 1-8 Fairmeadow, Maidstone, Kent, ME14 1JP
Final date for submission
11 September 2026
Contact
Hannah Bassom, Crowe UK LLP, [email protected]

What this notice means

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Read more: What is Liquidation?.

All notices for H2 Pharma Consulting Limited

3 Gazette notices on record for company no. 06206575, newest first. The full history, with last filed accounts, is on the H2 Pharma Consulting Limited company record.

  1. Appointment of liquidators (MVL) 21 Aug 2026
  2. Resolution for winding up (MVL) 21 Aug 2026

How does this notice affect you?

Choose what applies and we'll point you at the right next step.

Would rather just talk? 020 7720 8000

Related guidance

Free, practical guides from K2 on what this kind of notice means for directors.

More liquidation notices

← Back to all notices

Frequently asked questions

Is H2 Pharma Consulting Limited in financial difficulty?

No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Notices to creditors (MVL) for H2 Pharma Consulting Limited (company no. 06206575) on 21 August 2026.

What does a Notices to creditors (MVL) mean?

A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.

Who is dealing with the liquidation?

The office holders named in the notice: Mark Holborow (IP No. 22834) of Crowe UK LLP, 2nd Floor, Medway Bridge House, 1-8 Fairmeadow, Maidstone, Kent, ME14 1JP; Steven Edwards (IP No. 26090) of Crowe , appointed 17 August 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.

Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.